Biotia Company
Biotia launches beta testing of its technology platform to identify, analyze, track, and forecast infectious disease threats globally. Partnering with key organizations, the platform integrates climate, genomic, and epidemiological data with machine learning models to better track health threats and predict future crises.Biotia: Fighting infectious diseases, powered by genomics + AIwww.biotia.io/
Investors
Headquarters:
New York, United States
Industry:
Drug Repurposing
Employee Number:
1-10
Founded Date:
2016